The cytoprotective action of the potassium channel opener BMS-191095 in C2C12 myoblasts is related to the modulation of calcium homeostasis

Cellular Physiology and Biochemistry

Volumn 26, Issue 2, 2010, Pages 235-246

  Malinska, Dominika ^a   Kulawiak, Bogusz ^a   Wrzosek, Antoni ^a   Kunz, Wolfram S ^b   Szewczyk, Adam ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Calcium; Calpains; Cytoprotection; Mitochondria; Potassium channel opener BMS 191095

Indexed keywords

4 (4 CHLOROPHENYL) N (1H IMIDAZOL 2 YLMETHYL)DIMETHYL 2H 1 BENZOPYRAN 6 CARBONITRIL; BMS 191095; CALCIMYCIN; CALCIUM; CALPAIN; CYSTEINE PROTEINASE INHIBITOR; HYDROGEN PEROXIDE; PD 150606; POTASSIUM CHANNEL STIMULATING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL DAMAGE; CELL PROTECTION; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CYTOSOL; ENZYME ACTIVATION; ENZYME ACTIVITY; MITOCHONDRION; MYOBLAST; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM;

EID: 78049344269     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320523     Document Type: Article

References (61)

1. Escande D, Cavero I: K+ channel openers and 'natural' cardioprotection. Trends Pharmacol Sci 1992;13:269-272.
2. O'Rourke B: Mitochondrial ion channels. Annu Rev Physiol 2007;69:19-49.
3. Szewczyk A, Jarmuszkiewicz W, Kunz WS: Mitochondrial potassium channels. IUBMB Life 2009;61:134-143.
4. Nishida H, Matsumoto A, Tomono N, Hanakai T, Harada S, Nakaya H: Biochemistry and physiology of mitochon-drial ion channels involved in cardioprotection. FEBS Lett 2010;584:2161-2166.
5. Inoue I, Nagase H, Kishi K, Higuti T: ATP-sensitive K+ channel in the mito-chondrial inner membrane. Nature 1991;352:244-247.
6. Siemen D, Loupatatzis C, Borecky J, Gulbins E, Lang F: Ca2+-activated K channel of the BK-type in the inner mi-tochondrial membrane of a human glioma cell line. Biochem Biophys Res Commun 1999;257:549-554.
7. Szabò I, Bock J, Jekle A, Soddemann M, Adams C, Lang F, Zoratti M, Gulbins E: A novel potassium channel in lymphocyte mitochondria. J Biol Chem 2005;280:12790-12798.
8. Facundo HT, Fornazari M, Kowaltowski AJ: Tissue protection mediated by mito-chondrial K+ channels. Biochim Biophys Acta 2006;1762:202-212.
9. Murphy E., Steenbergen C: Preconditioning: the mitochondrial connection. Annu Rev Physiol 2007;69:51-67.
10. Kowaltowski AJ, Seetharaman S, Paucek P, Garlid KD: Bioenergetic consequences of opening the ATP-sensitive K(+) channel of heart mitochondria. Am J Physiol Heart Circ Physiol 2001;280:H649-H657.
11. Debska G, Kicinska A, Skalska J, Szewczyk A, May R, Elger CE, Kunz WS: Opening of potassium channels modulates mitochondrial function in rat skeletal muscle. Biochim Biophys Acta 2002;1556:97-105.
12. Dos Santos P, Kowaltowski AJ, Laclau MN, Seetharaman S, Paucek P, Boudina S, Thambo JB, Tariosse L, Garlid KD: Mechanisms by which opening the mi-tochondrial ATP-sensitive K(+) channel protects the ischemic heart. Am J Physiol Heart Circ Physiol 2002;283:H284-H295.
13. Facundo HT, de Paula JG, Kowaltowski AJ: Mitochondrial ATP-sensitive K+ channels prevent oxidative stress, permeability transition and cell death. J Bioenerg Biomembr 2005;37:5-82.
14. Sato T, Saito T, Saegusa N, Nakaya H: Mitochondrial Ca2+-activated K+ channels in cardiac myocytes: a mechanism of the cardioprotective effect and modulation by protein kinase A. Circulation 2005;111:198-203.
15. Samavati L, Monick MM, Sanlioglu S, Buettner GR, Oberley LW, Hunninghake GW: Mitochondrial K(ATP) channel openers activate the ERK kinase by an oxidant-dependent mechanism. Am J Physiol Cell Physiol 2002;283:C273-C281.
16. Sarre A, Lange N, Kucera P, Raddatz E: mitoKATP channel activation in the postanoxic developing heart protects EC coupling via NO-, ROS-, and PKC-de-pendent pathways. Am J Physiol Heart Circ Physiol 2005;288:H1611-H1619.
17. Hanley PJ, Daut J: K(ATP) channels and preconditioning: a re-examination of the role of mitochondrial K(ATP) channels and overview of alternative mechanisms. J Mol Cell Cardiol 2005;39:17-50.
18. Ockaili RA, Bhargava P, Kukreja RC: Chemical preconditioning with 3-nitropropionic acid in hearts: role of mi-tochondrial K(ATP) channel. Am J Physiol Heart Circ Physiol 2001;280:H2406-H2411.
19. Hanley PJ, Mickel M, Löffler M, Brandt U, Daut J: K(ATP) channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart. J Physiol 2002;542:735-741.
20. Holmuhamedov EL, Jahangir A, Oberlin A, Komarov A, Colombini M, Terzic A: Potassium channel openers are uncoupling protonophores: implication in cardioprotection. FEBS Lett 2004;568:167-170.
21. Rovnyak GC, Ahmed SZ, Ding CZ, Dzwonczyk S, Ferrara FN, Humphreys WG, Grover GJ, Santafianos D, Atwal KS, Baird AJ, McLaughlin LG, Normandin DE, Sleph PG, Traeger SC: Cardioselective antiischemic ATP-sensi-tive potassium channel (KATP) openers. 5. Identification of 4-(N-aryl)-sub-stituted benzopyran derivatives with high selectivity. J Med Chem 1997;40:24-34.
22. Mayanagi K, Gáspár T, Katakam PV, Kis B, Busija DW: The mitochondrial K(ATP) channel opener BMS-191095 reduces neuronal damage after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 2007;27:348-355.
23. Grover GJ, Burkett DE, Parham CS, Scalese RJ, Sadanaga KK: Protective effect of mitochondrial KATP activation in an isolated gracilis model of ischemia and reperfusion in dogs. J Cardiovasc Pharmacol 2003;42:790-792.
24. Grover GJ, D'Alonzo AJ, Garlid KD, Bajgar R, Lodge NJ, Sleph PG, Darbenzio RB, Hess TA, Smith MA, Paucek P, Atwal KS: Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity. J Pharmacol Exp Ther 2001;297:1184-1192.
25. Bednarczyk P, Dolowy K, Szewczyk A: New properties of mitochondrial ATP-regulated potassium channels. J Bioenerg Biomembr 2008;40:325-335.
26. Busija DW, Katakam P, Rajapakse NC, Kis B, Grover G, Domoki F, Bari F: Effects of ATP-sensitive potassium channel activators diazoxide and BMS-191095 on membrane potential and reactive oxygen species production in isolated piglet mitochondria. Brain Res Bull 2005;66:85-90.
27. Gaspar T, Snipes JA, Busija AR, Kis B, Domoki F, Bari F, Busija DW: ROS-inde-pendent preconditioning in neurons via activation of mitoKATP channels by BMS-191095. J Cereb Blood Flow Metab 2008;28:1090-1103.
28. Saito A, Seiler S, Chu A, Fleischer S: Preparation and morphology of sarco-plasmic reticulum terminal cisternae from rabbit skeletal muscle. J Cell Biol 1984;99:875-885.
29. Neckár J, Szárszoi O, Koten L, Papousek F, Ost'ádal B, Grover GJ, Kolár F: Effects of mitochondrial K(ATP) modulators on cardioprotection induced by chronic high altitude hypoxia in rats. Cardiovasc Res 2002;55:567-575.
30. Kis B, Nagy K, Snipes JA, Rajapakse NC, Horiguchi T, Grover GJ, Busija DW: The mitochondrial K(ATP) channel opener BMS-191095 induces neuronal preconditioning. Neuroreport 2004;15:345-349.
31. Murphy E., Steenbergen C: Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury. Physiol Rev 2008;88:581-609.
32. Vitadello M, Penzo D, Petronilli V, Michieli G, Gomirato S, Menabò R, Di Lisa F, Gorza L: Overexpression of the stress protein Grp94 reduces cardiomyocyte necrosis due to calcium overload and simulated ischemia. FASEB J 2003;17:923-925.
33. Oh KW, Qian T, Brenner DA, Lemasters JJ: Salicylate enhances necrosis and apoptosis mediated by the mitochondrial permeability transition. Toxicol Sci 2003;73:44-52.
34. Tauskela JS, Brunette E, Kiedrowski L, Lortie K, Hewitt M, Morley P: Unconventional neuroprotection against Ca2+-dependent insults by metalloporphyrin catalytic antioxidants. J Neurochem 2006;98:1324-1342.
35. Li S, Wu J, Watanabe M, Li C, Okada T: Protective effects of ischemic postconditioning against hypoxia-reoxygenation injury and hydrogen peroxide-induced damage in isolated rat hearts. Exp Clin Cardiol 2006;11:280-285.
36. Janero DR, Hreniuk D, Sharif HM, Prout KC: Hydroperoxide-induced oxidative stress alters pyridine nucleotide metabolism in neonatal heart muscle cells. Am J Physiol 1993;264:C1401-C1410.
37. Qian T, Herman B, Lemasters JJ: The mitochondrial permeability transition mediates both necrotic and apoptotic death of hepatocytes exposed to Br-A23187. Toxicol Appl Pharmacol 1999;154:117-125. (Pubitemid 29072493)
38. Goldman R, Moshonov S, Zor U: Generation of reactive oxygen species in a human keratinocyte cell line: role of calcium. Arch Biochem Biophys 1998;350:10-18.
39. Murata M, Akao M, O'Rourke B, Marbán E: Mitochondrial ATP-sensitive potassium channels attenuate matrix Ca(2+) overload during simulated ischemia and reperfusion: possible mechanism of cardioprotection. Circ Res 2001;89:891-898.
40. Ozcan C, Bienengraeber M, Dzeja PP, Terzic A: Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation. Am J Physiol Heart Circ Physiol 2002;282:H531-H539.
41. Akao M, O'Rourke B, Kusuoka H, Teshima Y, Jones SP, Marbán E: Differential actions of cardioprotective agents on the mitochondrial death pathway. Circ Res 2003;92:195-202.
42. Wang L, Kinnear C, Hammel JM, Zhu W, Hua Z, Mi W, Caldarone CA: Preservation of mitochondrial structure and function after cardioplegic arrest in the neonate using a selective mitochondrial KATP channel opener. Ann Thorac Surg 2006;81:1817-1823.
43. Ozcan C, Terzic A, Bienengraeber M: Effective pharmacotherapy against oxidative injury: alternative utility of an ATP-sensitive potassium channel opener. J Cardiovasc Pharmacol 2007;50:411-418.
44. Riess ML, Camara AK, Heinen A, Eells JT, Henry MM, Stowe DF: KATP channel openers have opposite effects on mitochondrial respiration under different energetic conditions. J Cardiovasc Pharmacol 2008;51:483-491.
45. Panov A, Scarpa A: Mg 2+ control of respiration in isolated rat liver mitochondria. Biochemistry 1996;35:12849-12856.
46. Tashiro M, Konishi M: Basal intracellu-lar free Mg2+ concentration in smooth muscle cells of guinea pig tenia cecum: intracellular calibration of the fluorescent indicator furaptra. Biophys J. 1997;73:3358-3370.
47. Moses MA, Addison PD, Neligan PC, Ashrafpour H, Huang N, Zair M, Rassuli A, Forrest CR, Grover GJ, Pang CY: Mi-tochondrial KATP channels in hindlimb remote ischemic preconditioning of skeletal muscle against infarction. Am J Physiol Heart Circ Physiol 2005;288:H559-H567.
48. Ahmad N, Wang Y, Haider KH, Wang B, Pasha Z, Uzun O, Ashraf M: Cardiac protection by mitoKATP channels is dependent on Akt translocation from cytosol to mitochondria during late preconditioning. Am J Physiol Heart Circ Physiol 2006;290:H2402-H2408.
49. Szewczyk A, Kajma A, Malinska D, Wrzosek A, Bednarczyk P, Zablocka B, Dolowy K: Pharmacology of mitochon-drial potassium channels: dark side of the field. FEBS Lett 2010;584:2063-2069.
50. Ray SK, Wilford GG, Crosby CV, Hogan EL, Banik NL: Diverse stimuli induce calpain overexpression and apoptosis in C6 glioma cells. Brain Res 1999;829:18-27.
51. Menconi MJ, Wei W, Yang H, Wray CJ, Hasselgren PO: Treatment of cultured myotubes with the calcium ionophore A23187 increases proteasome activity via a CaMK II-caspase-calpain-depend-ent mechanism. Surgery 2004;136:135-142.
52. Petersén A, Castilho RF, Hansson O, Wieloch T, Brundin P: Oxidative stress, mitochondrial permeability transition and activation of caspases in calcium ionophore A23187-induced death of cultured striatal neurons. Brain Res 2000;857:20-29.
53. Penzo D, Petronilli V, Angelin A, Cusan C, Colonna R, Scorrano L, Pagano F, Prato M, Di Lisa F, Bernardi P: Arachi-donic acid released by phospholipase A(2) activation triggers Ca(2+)-dependent apoptosis through the mitochondrial pathway.J Biol Chem 2004;279:25219-25225.
54. Wang KK, Nath R, Posner A, Raser KJ, Buroker-Kilgore M, Hajimohammadreza I, Probert AW, Marcoux FW, Lunney EA, Hays SJ, Yuen PW: An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective. Proc Natl Acad Sci \USA 1996;93:6687-6692.
55. Fariss MW, Reed DJ: Mechanism of chemical-induced toxicity. II. Role of extracellular calcium. Toxicol Appl Pharmacol 1985;79:296-306.
56. Martinez-Zaguilan R, Martinez GM, Gomez A, Hendrix MJC, Gillies RJ: Distinct regulation of pHin and [Ca2+]in in human melanoma cells with different metastatic potential. J Cell Physiol 1998;176:196-205.
57. Dedkova EN, Sigova AA, Zinchenko VP: Mechanism of action of calcium ionophores on intact cells: ionophore-resistant cells. Membr Cell Biol 2000;13:357-368.
58. Hamahata K, Adachi S, Matsubara H, Okada M, Imai T, Watanabe K, Toyokuni SY, Ueno M, Wakabayashi S, Katanosaka Y, Akiba S, Kubota M, Nakahata T: Mi-tochondrial dysfunction is related to necrosis-like programmed cell death induced by A23187 in CEM cells. Eur J Pharmacol 2005;516:187-196.
59. Holland DR, Armstrong WM, Steinberg MI: Calcium fluxes and contractility in isolated guinea pig atrium effect of A23187. Am J Physiol 1978;235:C13-C19.
60. Mahomed AG, Anderson R: Activation of human neutrophils with chemotactic peptide, opsonized zymosan and the calcium ionophore A23187, but not with a phorbol ester, is accompanied by efflux and store-operated influx of calcium. Inflammation 2000;24:559-569.
61. Dahlem YA, Wolf G, Siemen D, Horn TFW: Combined modulation of the mi-tochondrial ATP-dependent potassium channel and the permeability transition pore causes prolongation of the biphasic calcium dynamics. Cell Calcium 2006;39:387-400.